{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:02:54Z","timestamp":1772028174431,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04376-y","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:40:41Z","timestamp":1734590441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED ARTICLE: Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-3776","authenticated-orcid":false,"given":"Sabine","family":"Hazan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6478-2228","authenticated-orcid":false,"given":"Adriana C.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0677-7386","authenticated-orcid":false,"given":"Nicolas","family":"Hulscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Goudzwaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-6355","authenticated-orcid":false,"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon A.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"4376_CR1","unstructured":"Kai-Wang To K, Tak-Yin Tsang O, Chik-Yan Yip C, Chan KH, Wu TC, Chan M-C. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;12:ciaa149."},{"key":"4376_CR2","unstructured":"WHO. Transmission of SARS-CoV-2: implications for infection prevention precautions. 2020."},{"issue":"1","key":"4376_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7326\/M20-5008","volume":"174","author":"EA Meyerowitz","year":"2021","unstructured":"Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med. 2021;174(1):69\u201379.","journal-title":"Ann Intern Med"},{"key":"4376_CR4","doi-asserted-by":"publisher","first-page":"107672","DOI":"10.1016\/j.pharmthera.2020.107672","volume":"216","author":"ZN Lei","year":"2020","unstructured":"Lei ZN, Wu ZX, Dong S, Yang DH, Zhang L, Ke Z, Zou C, Chen ZS. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacol Ther. 2020;216:107672.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4376_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/07853890.2020.1839959","volume":"53","author":"P Bansal","year":"2021","unstructured":"Bansal P, Goyal A, Cusick A 4th, Lahan S, Dhaliwal HS, Bhyan P, Bhattad PB, Aslam F, Ranka S, Dalia T, Chhabra L, Sanghavi D, Sonani B, Davis JM 3. rd. hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019. Ann Med. 2021;53(1):117\u201334.","journal-title":"Ann Med"},{"key":"4376_CR6","unstructured":"FDA cautions against use of hydroxychloroquine or chloroquine for COVID. -19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. FDA. 2020 [cited 2024 Jul 9]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or"},{"key":"4376_CR7","unstructured":"Office of Surveillance and Epidemiology Review of Hydroxychloroquine and Chloroquine. FDA. 2020 [cited 2024 Jul 9]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/OSE Review_Hydroxychloroquine-Cholorquine - 19May2020_Redacted.pdf"},{"key":"4376_CR8","unstructured":"Nicholas J, Mercuro PD. QT Interval Prolongation and Hydroxychloroquine and Azithromycin in Hospitalized Patients With COVID-19. JAMA Cardiology, JAMA Network, 1 Sept. 2020, jamanetwork.com\/journals\/jamacardiology\/article-abstract\/2765631"},{"key":"4376_CR9","doi-asserted-by":"crossref","unstructured":"Francis Bessi\u00e8re MD. Assessment of QT intervals in a Case Series of patients with COVID-19 treated with hydroxychloroquine alone or in Combination with Azithromycin. JAMA Cardiology, JAMA Network, 1 Sept. 2020, jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2765633","DOI":"10.1001\/jamacardio.2020.1787"},{"issue":"12","key":"4376_CR10","doi-asserted-by":"publisher","first-page":"e017144","DOI":"10.1161\/JAHA.120.017144","volume":"9","author":"A Ramireddy","year":"2020","unstructured":"Ramireddy A, Chugh H, Reinier K, Ebinger J, Park E, Thompson M, Cingolani E, Cheng S, Marban E, Albert CM, Chugh SS. Experience with hydroxychloroquine and azithromycin in the Coronavirus Disease 2019 pandemic: implications for QT interval monitoring. J Am Heart Assoc. 2020;9(12):e017144.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"4376_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41591-020-0888-2","volume":"26","author":"E Chorin","year":"2020","unstructured":"Chorin E, Dai M, Shulman E, et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020;26(6):808\u20139.","journal-title":"Nat Med"},{"issue":"9","key":"4376_CR12","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","volume":"17","author":"E Chorin","year":"2020","unstructured":"Chorin E, Wadhwani L, Magnani S, et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin. Heart Rhythm. 2020;17(9):1425\u201333.","journal-title":"Heart Rhythm"},{"issue":"6","key":"4376_CR13","doi-asserted-by":"publisher","first-page":"e00866","DOI":"10.1161\/CIRCEP.120.008662","volume":"13","author":"M Saleh","year":"2020","unstructured":"Saleh M, Gabriels J, Chang D, et al. The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection. Circ Arrhythm Electrophysiol. 2020;13(6):e00866.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"4376_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5152\/akd.2015.5875","volume":"15","author":"C Rezu\u015f","year":"2015","unstructured":"Rezu\u015f C, Moga VD, Ouatu A, Floria M. QT interval variations and mortality risk: is there any relationship? Anatol J Cardiol. 2015;15(3):255\u20138.","journal-title":"Anatol J Cardiol"},{"issue":"2","key":"4376_CR15","doi-asserted-by":"publisher","first-page":"e051579","DOI":"10.1136\/bmjopen-2021-051579","volume":"12","author":"M El Kadri","year":"2022","unstructured":"El Kadri M, Al Falasi O, Ahmed R, Al Awadhi A, Altaha Z, Hillis A, Panikkaveetil B, Abdalla S, Ansel Benette H, Almubarak A, Saifuddin M, Alattar Y, Oulhaj A, AlKaabi S. Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study. BMJ Open. 2022;12(2):e051579.","journal-title":"BMJ Open"},{"issue":"4","key":"4376_CR16","doi-asserted-by":"publisher","first-page":"e216842","DOI":"10.1001\/jamanetworkopen.2021.6842","volume":"4","author":"GA Rubin","year":"2021","unstructured":"Rubin GA, Desai AD, Chai Z, Wang A, Chen Q, Wang AS, Kemal C, Baksh H, Biviano A, Dizon JM, Yarmohammadi H, Ehlert F, Saluja D, Rubin DA, Morrow JP, Avula UMR, Berman JP, Kushnir A, Abrams MP, Hennessey JA, Elias P, Poterucha TJ, Uriel N, Kubin CJ, LaSota E, Zucker J, Sobieszczyk ME, Schwartz A, Garan H, Waase MP, Wan EY. Cardiac corrected QT interval changes among patients treated for COVID-19 infection during the early phase of the pandemic. JAMA Netw Open. 2021;4(4):e216842.","journal-title":"JAMA Netw Open"},{"key":"4376_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/TCRM.S364022","volume":"18","author":"JC Lagier","year":"2022","unstructured":"Lagier JC, Million M, Cortaredona S, Delorme L, Colson P, Fournier PE, Brouqui P, Raoult D, Parola P. IHU Task Force. Outcomes of 2111 COVID-19 hospitalized patients treated with Hydroxychloroquine\/Azithromycin and other regimens in Marseille, France, 2020: a Monocentric Retrospective Analysis. Ther Clin Risk Manag. 2022;18:603\u201317.","journal-title":"Ther Clin Risk Manag"},{"key":"4376_CR18","doi-asserted-by":"publisher","first-page":"101188","DOI":"10.1016\/j.nmni.2023.101188","volume":"55","author":"P Brouqui","year":"2023","unstructured":"Brouqui P, Million M, Parola P, Mccullough PA, Raoult D. Outcomes after early treatment with hydroxychloroquine and azithromycin: an analysis of a database of 30,423 COVID-19 patients. New Microbes New Infect. 2023;55:101188.","journal-title":"New Microbes New Infect"},{"issue":"21","key":"4376_CR19","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","volume":"383","author":"P Horby","year":"2020","unstructured":"RECOVERY Collaborative Group, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. Effect of Hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;383(21):2030\u201340.","journal-title":"N Engl J Med"},{"issue":"6","key":"4376_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"H Pan","year":"2021","unstructured":"WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hern\u00e1ndez Garc\u00eda C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Periago R, Abi Hanna M, Ader P, Al-Bader F, Alhasawi AM, Allum A, Alotaibi E, Swaminathan A, S. Repurposed antiviral drugs for Covid-19 - interim WHO Solidarity Trial results. N Engl J Med. 2021;384(6):497\u2013511.","journal-title":"N Engl J Med"},{"key":"4376_CR21","doi-asserted-by":"publisher","unstructured":"Axfors C, Schmitt AM, Janiaud P, Van\u2019t Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen CP, Chen TC, Cheng SH, Cheng CY, Chung WS, Cohen YZ, Cowan LN, Dalgard O, de Almeida E, Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang YW, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo CY, Le T, Lin YC, Lin WP, Lin TH, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O\u2019Brien SM, Okeke NL, Perez L, Perez-Padilla R, Perrin L, Remigio-Luna A, Rivera-Martinez NE, Rockhold FW, Rodriguez-Llamazares S, Rolfe R, Rosa R, R\u00f8sj\u00f8 H, Sampaio VS, Seto TB, Shahzad M, Soliman S, Stout JE, Thirion-Romero I, Troxel AB, Tseng TY, Turner NA, Ulrich RJ, Walsh SR, Webb SA, Weehuizen JM, Velinova M, Wong HL, Wrenn R, Zampieri FG, Zhong W, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021;12(1):2349. https:\/\/doi.org\/10.1038\/s41467-021-22446-z. Erratum in: Nat Commun. 2021;12(1):3001.","DOI":"10.1038\/s41467-021-22446-z"},{"key":"4376_CR22","doi-asserted-by":"publisher","first-page":"116055","DOI":"10.1016\/j.biopha.2023.116055","volume":"171","author":"A Pradelle","year":"2024","unstructured":"Pradelle A, Mainbourg S, Provencher S, Massy E, Grenet G, Lega JC. Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate. Biomed Pharmacother. 2024;171:116055.","journal-title":"Biomed Pharmacother"},{"key":"4376_CR23","doi-asserted-by":"crossref","unstructured":"Cersosimo A, Cimino G, Amore L, Calvi E, Pascariello G, Inciardi RM, Lombardi CM, Vizzardi E, Metra M. Cardiac biomarkers and mortality in COVID-19 infection: a review. Monaldi Arch Chest Dis. 2022;93(1).","DOI":"10.4081\/monaldi.2022.2276"},{"key":"4376_CR24","doi-asserted-by":"publisher","unstructured":"Mazzanti A et al. June. Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19. Circulation, 5 2020, www.ahajournals.https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048476","DOI":"10.1161\/CIRCULATIONAHA.120.048476"},{"issue":"2","key":"4376_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","volume":"12","author":"LX Cubeddu","year":"2016","unstructured":"Cubeddu LX. Drug-induced inhibition and trafficking disruption of ion channels: Pathogenesis of QT abnormalities and Drug-induced fatal arrhythmias. Curr Cardiol Rev. 2016;12(2):141\u201354.","journal-title":"Curr Cardiol Rev"}],"updated-by":[{"DOI":"10.1186\/s12872-025-04554-6","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"record-id":"62219"},{"DOI":"10.1186\/s12872-025-04554-6","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000}}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04376-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04376-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04376-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:32:13Z","timestamp":1739889133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04376-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4376"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04376-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12872-025-04554-6","URL":"https:\/\/doi.org\/10.1186\/s12872-025-04554-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves human participants, and the study protocol was reviewed and approved by The Salus Institutional Review Board, Protocol #20071 and registered at Clinicaltrials.gov, Identifier NCT04482686. Participants gave informed consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave consent for publication. Participants gave written informed consent for their unidentified personal or clinical details along with any images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Hazan is the CEO of Progenabiome, LLC and owns the Microbiome Research Foundation. Dr. McCullough owns the McCullough Foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr Hazan is the CEO of Progenabiome, LLC and owns the Microbiome Research Foundation. Dr. McCullough owns the McCullough Foundation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"710"}}